Relay Therapeutics, Inc. (RLAY) Misses Q3 EPS by 1c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q3 EPS of ($0.43), $0.01 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity